Live Active Patient EHR Data ICON and Practice Fusion extend partnership to provide live Active Patient EHR data for clinical records. Disruptive Innovation – The Impact Read the views of 3 Senior Pharma Executives on how their organisations are approaching innovation. FIRECREST Site performance ignited: Digital solutions increase efficiency in clinical trials by driving site performance. ICON Insights 18 September 2018 Smart Bioanalytical Strategies in Immuno-Oncology Trials Discover the latest biomarker-based methods and how they can be leveraged to add value to oncology trials. Read more 29 August 2018 CDISC Legacy Data Conversion ICON’s Data Management team provides advice and guidance on legacy conversion process and what you need to implement to remain compliant. Read more 27 August 2018 Precision Medicine Opportunities for Device Developers Medical device developers are emerging into the precision medicine market in a variety of therapeutic areas, including neurology, cardiology and infectious diseases. Read more 01 August 2018 Five Key Considerations for Writing First-in-Human Protocols Under EMA Guidelines As pharmaceuticals move from animal to first-in-human (FIH) clinical trials, establishing appropriate strategies to minimise risk in early phase clinical trials is necessary. Read more 04 July 2018 What Motivates Patients to Participate in Multiple Clinical Trials? Successful clinical trial recruitment requires a thorough understanding of the target patient profile, and a key factor within this profile is patient motivation. Read more 25 June 2018 FDA Acceptance of Clinical Data Collected Outside the U.S. The US Food & Drug Administration (FDA) amended requirements for the acceptance of clinical data cllected outside the US to support medical device submissions. Read more 21 June 2018 Harnessing Blockchain Technology and Digital Disruption The opportunity for blockchain in healthcare and clinical trials. Read more 15 June 2018 The Future of Automation and Digital Transformation in Late Phase Research Late phase studies are ripe for digitalisation, although not always in the same ways as Phase II and III programs. Read more 14 June 2018 Biostatistics: Using Restricted Mean Survival Time (RMST) in Oncology Trials to Improve Outcomes Learn how to use biostatistics using RMST in Oncological trials to improve clinical outcomes Read more What’s happening in ICON Contact About ICON Results & Reports For Clients Therapeutics Services Insights Innovation ICON For Investigators Mediakit Volunteers Investors Jobs & Careers News & Events Press Releases Events ICON on Social Media LinkedIn Twitter Facebook Youtube © 2018 ICON plc Disclaimer Privacy Site Cookies